ATP regulation in ClC-3 exchangers linked to neurodegenerative diseases, study reveals

FHS
August 11, 2024
11:49 pm

Researchers structurally analyzed adenine nucleotide control and neurodegenerative diseases in ClC-3 exchangers.

Study reveals unintended consequences of antibiotic choice in sepsis treatment

In emergency rooms and intensive care units across the country, clinicians make split-second decisions about which antibiotics to give a patient when a life-threatening infection

May 14, 2024

Eloxx moves ahead with plans with gene therapy for rare kidney disorder – Pharmaceutical Technology

Eloxx Pharmaceuticals is developing a therapy for the rare kidney disorder Alport syndrome. Credit: Ivan-balvan via Getty Images. US-based biotech Eloxx Pharmaceuticals announced the submission

September 8, 2023

J&J’s Ottava surgical robot to begin clinical trial after FDA nod

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Johnson & Johnson said Tuesday

November 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.